Cancer Be Damned

Teenager Lauren Bendesky turned her cancer diagnosis on its head, using herself as a research subject to test potential therapies.

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

A SURVIVOR’S STORY: Lauren Bendesky credits persistent positivity with helping her to defeat neuroblastoma while excelling in school and striving to reach her career goals. COURTESY OF LAUREN BENDESKY

A cancer diagnosis often claims more than a pound of flesh, damaging many patients’ energy, motivation, and sense of hope along with their bodies. But not if that patient is Lauren Bendesky. In May 2012, when she was 14 years old, doctors in Bendesky’s home state of Florida removed a fifteen-and-a-half-pound tumor from her abdomen. Their diagnosis: Stage 4 neuroblastoma, a cancer that usually attacks infants or toddlers and can vary from a death sentence to a disease treatable with several modern therapies.

“There was a week or so—not that I was really depressed or not OK with what was going on—that I kind of questioned why I had to go through this,” Bendesky, now 18 years old, told The Scientist. But that brief moment ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo